SUMO2 and liver cancer: Meanwhile, the Kaplan–Meier analysis of 364 patients with liver cancer (www.kmplot.com; public database website) showed that the total survival time in patients with high level of SUMO2 expression was significantly shorter than that in patients with low SUMO2 expression level (Fig. 1C).